InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Palmer Ashleigh, Chairman & CEO. Director active across 1 company, notably Provention Bio, Inc.. Cumulatively, 4 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €22k. History available since 30 November 2021. The latest transaction was disclosed on 10 February 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Ashleigh Palmer is the Director and CEO of Provention Bio, Inc. She leads the company by defining its strategic vision and overseeing its operations. Her expertise in the biopharmaceutical field enables her to guide Provention Bio towards cutting-edge innovations and therapeutic solutions.